Filings Received and Processed at the SEC

Vanderhook Timothy

1843103 ⦿ 0001843103-26-000014

Form 4 Reporting

Viant Technology Inc.

1828791 ⦿ 0001843103-26-000014

Form 4 Issuer

Vanderhook Christopher

1843104 ⦿ 0001843104-26-000014

Form 4 Reporting

Viant Technology Inc.

1828791 ⦿ 0001843104-26-000014

Form 4 Issuer

Capital V LLC

1844767 ⦿ 0001844767-26-000012

Form 4 Reporting

Viant Technology Inc.

1828791 ⦿ 0001844767-26-000012

Form 4 Issuer

Scribe Therapeutics, Inc.

1853921 ⦿ 0001193125-26-314787

Form 3 Issuer

ELI LILLY & Co

59478 ⦿ 0001193125-26-314787

Form 3 Reporting

Kim Vyacheslav

2029485 ⦿ 0001193125-26-314785

Form 4 Reporting

Joint Stock Co Kaspi.kz

1985487 ⦿ 0001193125-26-314785

Form 4 Issuer

Scribe Therapeutics, Inc.

1853921 ⦿ 0000947871-26-000715

Form 3 Issuer

OrbiMed Capital GP VIII LLC

1845804 ⦿ 0000947871-26-000715

Form 3 Reporting

ORBIMED ADVISORS LLC

1055951 ⦿ 0000947871-26-000715

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0001231919-26-000795

Form 3 Issuer

AH Equity Partners Bio III, L.L.C.

1799478 ⦿ 0001231919-26-000795

Form 3 Reporting

AH Bio Fund III, L.P.

1799477 ⦿ 0001231919-26-000795

Form 3 Reporting

AH Equity Partners Bio II, L.L.C.

1725722 ⦿ 0001231919-26-000795

Form 3 Reporting

AH Bio Fund II, L.P.

1725721 ⦿ 0001231919-26-000795

Form 3 Reporting

HOROWITZ BENJAMIN A

1166586 ⦿ 0001231919-26-000795

Form 3 Reporting

Andreessen Marc L

1160077 ⦿ 0001231919-26-000795

Form 3 Reporting

McManus Matt

2067206 ⦿ 0001193125-26-314771

Form 4 Reporting

Fold Holdings, Inc.

1889123 ⦿ 0001193125-26-314771

Form 4 Issuer

Staahl Brett

2147277 ⦿ 0002147277-26-000001

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0002147277-26-000001

Form 3 Issuer

Scribe Therapeutics, Inc.

1853921 ⦿ 0001739090-26-000008

Form 3 Issuer

Doudna Jennifer A

1739090 ⦿ 0001739090-26-000008

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0001282930-26-000002

Form 3 Issuer

GORDON CARL L

1282930 ⦿ 0001282930-26-000002

Form 3 Reporting

Watson James Dean

2130384 ⦿ 0002130384-26-000002

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0002130384-26-000002

Form 3 Issuer

Artiva Biotherapeutics, Inc.

1817241 ⦿ 0001346824-26-000203

Form SCHEDULE 13D/A Subject

RA CAPITAL MANAGEMENT, L.P.

1346824 ⦿ 0001346824-26-000203

Form SCHEDULE 13D/A Filed by

RA Capital Nexus Fund III, L.P.

1883840 ⦿ 0001231919-26-000791

Form 4 Reporting

Artiva Biotherapeutics, Inc.

1817241 ⦿ 0001231919-26-000791

Form 4 Issuer

RA Capital Nexus Fund, L.P.

1780117 ⦿ 0001231919-26-000791

Form 4 Reporting

Shah Rajeev M.

1619841 ⦿ 0001231919-26-000791

Form 4 Reporting

Kolchinsky Peter

1384859 ⦿ 0001231919-26-000791

Form 4 Reporting

RA CAPITAL MANAGEMENT, L.P.

1346824 ⦿ 0001231919-26-000791

Form 4 Reporting

RA Capital Healthcare Fund LP

1315082 ⦿ 0001231919-26-000791

Form 4 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0001781292-26-000005

Form 3 Issuer

Lucas Svetlana

1781292 ⦿ 0001781292-26-000005

Form 3 Reporting

RA Capital Nexus Fund III, L.P.

1883840 ⦿ 0001231919-26-000790

Form 4/A Reporting

Artiva Biotherapeutics, Inc.

1817241 ⦿ 0001231919-26-000790

Form 4/A Issuer

RA Capital Nexus Fund, L.P.

1780117 ⦿ 0001231919-26-000790

Form 4/A Reporting

Shah Rajeev M.

1619841 ⦿ 0001231919-26-000790

Form 4/A Reporting

Kolchinsky Peter

1384859 ⦿ 0001231919-26-000790

Form 4/A Reporting

RA CAPITAL MANAGEMENT, L.P.

1346824 ⦿ 0001231919-26-000790

Form 4/A Reporting

RA Capital Healthcare Fund LP

1315082 ⦿ 0001231919-26-000790

Form 4/A Reporting

Oakes Benjamin L.

2127814 ⦿ 0002127814-26-000002

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0002127814-26-000002

Form 3 Issuer

Bleharski Joshua

2075052 ⦿ 0002075052-26-000002

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0002075052-26-000002

Form 3 Issuer

Parrot David

2127908 ⦿ 0002127908-26-000002

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0002127908-26-000002

Form 3 Issuer

Allen Dominic Paul

2145923 ⦿ 0002145923-26-000001

Form SCHEDULE 13G Filed by

Rare Earths Americas, Inc.

2095743 ⦿ 0002145923-26-000001

Form SCHEDULE 13G Subject

Avoro Ventures LLC

1879253 ⦿ 0000902664-26-003226

Form 3 Reporting

Scribe Therapeutics, Inc.

1853921 ⦿ 0000902664-26-003226

Form 3 Issuer

Aghazadeh Behzad

1701815 ⦿ 0000902664-26-003226

Form 3 Reporting

Avoro Capital Advisors LLC

1633313 ⦿ 0000902664-26-003226

Form 3 Reporting

TENG CHIN-CHI

1751946 ⦿ 0000813672-26-000085

Form 4 Reporting

CADENCE DESIGN SYSTEMS INC

813672 ⦿ 0000813672-26-000085

Form 4 Issuer

Robinhood Ventures Fund I

2085091 ⦿ 0000950103-26-011121

Form SCHEDULE 13G/A Subject

Robinhood Markets, Inc.

1783879 ⦿ 0000950103-26-011121

Form SCHEDULE 13G/A Filed by

Brookfield Infrastructure Corp

1788348 ⦿ 0001104659-26-086412

Form SCHEDULE 13D/A Subject

BROOKFIELD Corp /ON/

1001085 ⦿ 0001104659-26-086412

Form SCHEDULE 13D/A Filed by

Rotsztain Diego

1511110 ⦿ 0001511110-26-000008

Form 4 Reporting

StoneX Group Inc.

913760 ⦿ 0001511110-26-000008

Form 4 Issuer

OCONNOR SEAN MICHAEL

1208362 ⦿ 0001208362-26-000011

Form 4 Reporting

StoneX Group Inc.

913760 ⦿ 0001208362-26-000011

Form 4 Issuer

Dunaway William J

1405955 ⦿ 0001405955-26-000007

Form 4 Reporting

StoneX Group Inc.

913760 ⦿ 0001405955-26-000007

Form 4 Issuer

Brookfield Infrastructure Partners L.P.

1406234 ⦿ 0001104659-26-086411

Form SCHEDULE 13D/A Subject

BROOKFIELD Corp /ON/

1001085 ⦿ 0001104659-26-086411

Form SCHEDULE 13D/A Filed by

Smith Philip Andrew

1569789 ⦿ 0001569789-26-000012

Form 4 Reporting

StoneX Group Inc.

913760 ⦿ 0001569789-26-000012

Form 4 Issuer

Maurer Mark Lowry

1662210 ⦿ 0001662210-26-000011

Form 4 Reporting

StoneX Group Inc.

913760 ⦿ 0001662210-26-000011

Form 4 Issuer

Peter Warwick

1620586 ⦿ 0001620586-26-000009

Form 4 Reporting

SCHOLASTIC CORP

866729 ⦿ 0001620586-26-000009

Form 4 Issuer

Intrator Michael N

2058037 ⦿ 0001769628-26-000327

Form 4 Reporting

CoreWeave, Inc.

1769628 ⦿ 0001769628-26-000327

Form 4 Issuer

Lynrock Lake Master Fund LP

1736419 ⦿ 0000921895-26-001861

Form 144 Reporting

RADCOM LTD

1016838 ⦿ 0000921895-26-001861

Form 144 Subject

Outlook Therapeutics, Inc.

1649989 ⦿ 0001649989-26-000007

Form 4 Issuer

KENYON LAWRENCE A

1230484 ⦿ 0001649989-26-000007

Form 4 Reporting

B&R Technology Sponsor LLC

2146375 ⦿ 0001193125-26-314704

Form 4 Reporting

B&R Technology Merger Corp.

2131350 ⦿ 0001193125-26-314704

Form 4 Issuer

Fletcher Steven C.

1804143 ⦿ 0001193125-26-314704

Form 4 Reporting

Andersen Stacia J.P.

1677473 ⦿ 0000906553-26-000062

Form 4 Reporting

BOYD GAMING CORP

906553 ⦿ 0000906553-26-000062

Form 4 Issuer

D'Ambra Casey Alexandra

2144234 ⦿ 0001493152-26-034451

Form 3 Reporting

NextTrip, Inc.

788611 ⦿ 0001493152-26-034451

Form 3 Issuer

8 Rivers Capital, LLC

1981100 ⦿ 0001104659-26-086400

Form 4 Reporting

BEAUCHAMP DAMIAN R.

1973442 ⦿ 0001104659-26-086400

Form 4 Reporting

NET Power Inc.

1845437 ⦿ 0001104659-26-086400

Form 4 Issuer

Murtagh Nigel J

1649599 ⦿ 0001649599-26-000009

Form 4 Reporting

SCHWAB CHARLES CORP

316709 ⦿ 0001649599-26-000009

Form 4 Issuer

NPEH, LLC

1981772 ⦿ 0001104659-26-086399

Form 4 Reporting

NET Power Inc.

1845437 ⦿ 0001104659-26-086399

Form 4 Issuer